Next Generation News and Research

RSS

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Axonics Modulation Technologies, Inc., a developer of novel implantable neuromodulation technology, announced today that it has completed a $32.6 million Series A preferred stock financing.

25 Mar 2014

Precision for Medicine announces acquisition of Hobart Group Holdings

Precision for Medicine, Inc., formed in 2012 to support next generation approaches to drug development and commercialization, announces the acquisition of Hobart Group Holdings, LLC, a leading market access firm. With this addition, Precision for Medicine has established the foundation for its next phase of growth in providing integrated solutions focused on demonstrating value in the era of precision medicine.

25 Mar 2014

Faster DNA sequencing techniques more likely to improve care for patients with breast cancer

Faster and cheaper DNA sequencing techniques will likely improve care for patients with breast cancer but also create challenges for clinicians as they counsel patients on their treatment options.

25 Mar 2014

Viewpoints: Supreme Court on religion and health; a GOP Senate's effect on health law; where are the young adults?

Should corporations have the right to get out of obeying federal law and refuse services and deny health care coverage to some people because of the corporate owners' religious beliefs? That's the question the U.S. Supreme Court is weighing this month – and the answer could affect millions of Americans' everyday lives (Cecile Richards and Chad Griffin, 3/18).

20 Mar 2014

New drug for patients with leukaemia and lymphoma puts an end to chemotherapy

Patients with terminal forms of leukaemia and lymphoma who have run out of treatment options could soon benefit from a new drug, which not only puts an end to chemotherapy and has virtually no side effects but also improves a patient's life expectancy and quality of life.

20 Mar 2014

Trovagene reports net loss of $1 million for fourth quarter 2013

Trovagene, Inc., a developer of cell-free molecular diagnostics, today reported its financial results for the quarter and the year ended December 31, 2013.

18 Mar 2014

Loyola urogynecologist receives 2014 Christina Manthos Mentoring Award from SWIU

Elizabeth Mueller, MD, MS, has been named a 2014 Christina Manthos Mentoring Award recipient by the Society of Women in Urology (SWIU). Dr. Mueller is the division director and the fellowship program director of Female Pelvic Medicine & Reconstructive Surgery at Loyola University Health System.

18 Mar 2014

Researchers present science and engineering research in Parliament

Two researchers from the University of Hertfordshire are attending Parliament to present their science to a range of politicians and a panel of expert judges as part of SET for Britain on Monday 17th March.

17 Mar 2014

New crowd funding campaign supports dementia patients

Opaque Multimedia and Alzheimer's Australia Vic today announced the launch of a Pozible crowd funding campaign to support the development of The Forest Project - a video game application designed to improve the quality of life of people living with dementia through the use of Epic Games' Unreal Engine 4 technology.

17 Mar 2014

RTI Surgical launches 2 new biological solutions at AAOS annual meeting in New Orleans

RTI Surgical Inc., a leading global surgical implant company, is launching two new biological solutions at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans this week. NanOss Bioactive 3D, a synthetic three dimensional bioscaffold which supports bone formation, and map3™ Cellular Allogeneic Bone Graft, an implant that contains the three essential elements needed to generate and maintain new bone, will be introduced at the RTI Surgical exhibit at booth 5937 (Hall H) during the AAOS meeting.

12 Mar 2014

Teen researcher wins top award from Intel Foundation for research on potential drugs to treat influenza

From new cancer treatments to an exploration of how technology affects the adolescent brain, the innovative research of America's future scientists, engineers and inventors took center stage in the nation's capital today.

12 Mar 2014

Experimental drugs offer hope for people with hepatitis C

Patrizia Cazzaniga had heard the horror stories about early treatments for hepatitis C - multiple daily pills and weekly shots for up to a year, side effects that could be debilitating, and a cure rate of only about 40 percent.

11 Mar 2014

Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

Brain Resource has announced today that Robert Bosch Healthcare Systems, Inc. (headquarters in Palo Alto, California, USA), the market leader in evidence-based telehealth solutions, has added MyBrainSolutions to their newly launched Health Buddy Web solution for the monitoring, education, and management of people living with chronic conditions.

10 Mar 2014

UTMB receives $3.2M grant to continue research on cancer treatments and outcomes in Texas

The Cancer Prevention and Research Institute of Texas has awarded the University of Texas Medical Branch at Galveston more than $3.2 million to continue a program aimed at creating a new state resource - a trove of population research on cancer treatments and outcomes in Texas.

10 Mar 2014

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a key biomarker for inflammation. Studies show that MPO levels are useful predictors of near-term (one to six months) risk of heart attack or stroke.

6 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

President Obama's budget: Medicare means testing and lower drug costs

The budget proposal includes a provision to make wealthier seniors in Medicare pay more as well and another to try to drive down the cost of prescription drugs. A rival Republican plan is also expected to propose cuts to Medicare and Medicaid.

6 Mar 2014

First Edition: March 5, 2014

Today's headlines include reports about President Barack Obama's 2015 budget as well as the latest state-level Medicaid expansion developments.

5 Mar 2014

Eisai collaborates with Biogen Idec to develop and commercialize treatment options for AD

Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.

5 Mar 2014

Bruker announces next generation JuiceScreener™ 3.0

At Pittcon 2014, Bruker today announced the third release of its successful NMR JuiceScreenerTM. The new release comes with significant enhancements that enable the accurate, swift, automated screening of even more fruit juice types from just a single experiment.

4 Mar 2014

Next Generation News and Research

Axonics Modulation Technologies completes $32.6 million Series A preferred stock financing

Precision for Medicine announces acquisition of Hobart Group Holdings

Faster DNA sequencing techniques more likely to improve care for patients with breast cancer

Viewpoints: Supreme Court on religion and health; a GOP Senate's effect on health law; where are the young adults?

New drug for patients with leukaemia and lymphoma puts an end to chemotherapy

Trovagene reports net loss of $1 million for fourth quarter 2013

Loyola urogynecologist receives 2014 Christina Manthos Mentoring Award from SWIU

Researchers present science and engineering research in Parliament

New crowd funding campaign supports dementia patients

RTI Surgical launches 2 new biological solutions at AAOS annual meeting in New Orleans

Teen researcher wins top award from Intel Foundation for research on potential drugs to treat influenza

Experimental drugs offer hope for people with hepatitis C

Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

UTMB receives $3.2M grant to continue research on cancer treatments and outcomes in Texas

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

President Obama's budget: Medicare means testing and lower drug costs

First Edition: March 5, 2014

Eisai collaborates with Biogen Idec to develop and commercialize treatment options for AD

Bruker announces next generation JuiceScreener™ 3.0

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News